Qilian International Holding Group Ltd Ordinary Shares QLI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.70
- Day Range
- $0.68–0.68
- 52-Week Range
- $0.37–1.15
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $24.31 Mil
- Volume/Avg
- 5,766 / 169,814
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.52
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 298
- Website
- http://ir.qlsyy.net
Valuation
Metric
|
QLI
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.57 |
Price/Sales | 0.52 |
Price/Cash Flow | — |
Price/Earnings
QLI
Financial Strength
Metric
|
QLI
|
---|---|
Quick Ratio | 4.32 |
Current Ratio | 5.18 |
Interest Coverage | — |
Quick Ratio
QLI
Profitability
Metric
|
QLI
|
---|---|
Return on Assets (Normalized) | −4.33% |
Return on Equity (Normalized) | −5.24% |
Return on Invested Capital (Normalized) | −5.15% |
Return on Assets
QLI
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Gtnmcvwcv | Xxvxn | $75.7 Bil | |
MKKGY
| Merck KGaA ADR | Qrglzfldm | Gnbbzj | $71.1 Bil | |
HLN
| Haleon PLC ADR | Nxlzgcjn | Frsw | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Vmvnpvlx | Qkr | $15.9 Bil | |
VTRS
| Viatris Inc | Pkjmpbt | Jth | $14.1 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Fwhzylpx | Nhbh | $12.7 Bil | |
CTLT
| Catalent Inc | Psdntpmkd | Qdqxvwg | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Tqxjght | Sfjp | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Rbpxnfq | Qfdp | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vmxyqndy | Vyhfn | $3.5 Bil |